Review





Similar Products

pd98059  (MedChemExpress)
96
MedChemExpress pd98059
CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following <t>PD98059</t> or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).
Pd98059, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd98059/product/MedChemExpress
Average 96 stars, based on 1 article reviews
pd98059 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
cat#  (MedChemExpress)
96
MedChemExpress cat#
CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following <t>PD98059</t> or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).
Cat#, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cat#/product/MedChemExpress
Average 96 stars, based on 1 article reviews
cat# - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
thyca ko dectin1 pd98059 group  (MedChemExpress)
96
MedChemExpress thyca ko dectin1 pd98059 group
CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following <t>PD98059</t> or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).
Thyca Ko Dectin1 Pd98059 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thyca ko dectin1 pd98059 group/product/MedChemExpress
Average 96 stars, based on 1 article reviews
thyca ko dectin1 pd98059 group - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
item number hy  (MedChemExpress)
96
MedChemExpress item number hy
CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following <t>PD98059</t> or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).
Item Number Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/item number hy/product/MedChemExpress
Average 96 stars, based on 1 article reviews
item number hy - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following PD98059 or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).

Journal: International Dental Journal

Article Title: Calpain-1 Potentiates Periodontal Regeneration via PHLPP1-ERK-Driven Osteogenesis in Periodontal Ligament Stem Cells

doi: 10.1016/j.identj.2025.109309

Figure Lengend Snippet: CAPN1 facilitated the osteogenic differentiation of hPDLSCs through the ERK signalling pathway . (A) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs with or without lentivirus transfection. (B) Quantification of the images in A. (C) Representative Western blot for CAPN1, p-ERK1/2, and ERK1/2 in hPDLSCs following siRNAs treatment. (D) Quantification of the images in C. (E) Representative Western blot for PHLPP1 in hPDLSCs following siRNAs treatment and quantification of the images. (F) Quantification of the images in E. (G) Representative Western blot for PHLPP1 in hPDLSCs following Calpeptin treatment. (H) Quantification of the images in G. (I) Representative Western blot for CAPN1, ERK1/2, and p-ERK1/2 in hPDLSCs following PD98059 or Calpeptin treatment. (J) Quantification of the images in J. (K) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following increasing NSC45586 doses treatment. (L) Quantification of the images in J. (M) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following siPHLPP1 treatment. (N) Quantification of the images in M. (O) Representative Western blot for PHLPP1, ERK1/2, p-ERK1/2 in hPDLSCs following si CAPN1 or si CAPN1 combined with NSC45586 treatment. (P) Quantification of the images in O. Mean ± SD was employed to express all data (ns P > .05, ∗ P < .05, ∗∗ P < .01, *** P < .001, **** P < .0001).

Article Snippet: PDLSCs were cultured separately with 100 μM Calpeptin (MedChemExpress), 15 μM PD98059 (MedChemExpress), or equivalent DMSO (vehicle) in osteogenic medium for 3 days and washed twice with PBS before total protein extraction.

Techniques: Western Blot, Transfection